Cardiac MRI Biomarker Testing (GCC 1618)
Cardiac Magnetic Resonance Imaging and Biomarker Testing for Evaluating Cardiac Injury Resulting From Radiation Therapy in Cancer: A Pilot Study
Sponsor: University of Maryland, Baltimore
Terminated
Unable to meet accrual goal
Other terminated trials from University of Maryland, Baltimore
Other Breast Cancer trials with similar outcome
A observational or N/A phase clinical study on Breast Cancer and Lung Cancer (Non-Small Cell), this trial is terminated or withdrawn. The trial is conducted by University of Maryland, Baltimore and has accumulated 13 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Nov 2022 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2021 — Nov 2022 [monthly]
Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Dec 2019 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Recruiting
-
Jun 2019 — Sep 2019 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting · Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .